Date | Analyst | Company | Last | Target | Call | Valuation |
01/04/23 | UOB Kay Hian | Genting | 0.95 | 1.08 | Buy | |
01/09/23 | UOB Kay Hian | Genting | 0.97 | 1.15 | Buy | EV/Ebitda9.3x FY23 |
01/27/23 | Citi Research | Genting | 1 | 1.04 | Buy | Sum of parts |
01/31/23 | Morgan Stanley | Genting | 0.975 | 1.15 | Overweight | Up from $0.85 |
01/31/23 | Kim Eng | Genting | 0.975 | 0.94 | Hold | |
01/31/23 | OCBC | Genting | 0.975 | 1.06 | Buy | |
02/21/23 | UOB Kay Hian | Genting | 1 | 1.15 | Buy | EV/Ebitda9.3x FY23 |
02/21/23 | DBS Vickers | Genting | 1 | 1.05 | Hold | EV/Ebitda9x FY23 |
02/21/23 | Citi Research | Genting | 1 | 1.2 | Buy | |
02/21/23 | Lim & Tan | Genting | 1 | 1.1 | Hold | |
03/14/23 | Kim Eng | Genting | 1.02 | 0.96 | Hold | |
03/20/23 | Kim Eng | Genting | 1.06 | 1.18 | Buy | DCF |
04/20/23 | DBS Vickers | Genting | 1.13 | 1.05 | Hold | |
04/21/23 | CIMB | Genting | 1.14 | 1.26 | Add | EV/Ebitda10x FY24 |
04/21/23 | Citi Research | Genting | 1.14 | 1.36 | Buy | |
04/27/23 | UOB Kay Hian | Genting | 1.14 | 1.25 | Buy | EV/Ebitda9.9x FY23 |
05/15/23 | UOB Kay Hian | Genting | 1.11 | 1.25 | Buy | EV/Ebitda9.9x FY23 |
05/15/23 | DBS Vickers | Genting | 1.11 | 1.05 | Hold | Sum of parts |
05/15/23 | CIMB | Genting | 1.11 | 1.26 | Add | EV/Ebitda10x FY24 |
05/15/23 | Citi Research | Genting | 1.11 | 1.26 | Buy | |
07/04/23 | Kim Eng | Genting | 0.945 | 1.12 | Buy | |
07/06/23 | UOB Kay Hian | Genting | 0.935 | 1.25 | Buy | |
07/21/23 | Citi Research | Genting | 0.95 | 1.23 | Buy | |
07/25/23 | CLSA | Genting | 0.93 | 1.26 | Buy | |
08/11/23 | DBS Vickers | Genting | 0.92 | 1 | Hold | Sum of parts |
08/14/23 | CIMB | Genting | 0.955 | 1.3 | Add | EV/Ebitda |
08/14/23 | Kim Eng | Genting | 0.955 | 1.12 | Buy | DCF |
08/14/23 | Citi Research | Genting | 0.955 | 1.26 | Buy | Sum of parts |
09/25/23 | DBS Vickers | Genting | 0.85 | 1 | Hold | |
10/19/23 | UOB Kay Hian | Genting | 0.84 | 1.25 | Buy | |
10/20/23 | Citi Research | Genting | 0.83 | 1.26 | Buy | |
10/20/23 | CIMB | Genting | 0.83 | 1.3 | Add | |
11/14/23 | UOB Kay Hian | Genting | 0.85 | 1.25 | Buy | EV/Ebitda9x FY24 |
11/14/23 | DBS Vickers | Genting | 0.85 | 1.05 | Buy | Sum of parts |
11/14/23 | CIMB | Genting | 0.85 | 1.3 | Add | |
11/14/23 | Citi Research | Genting | 0.85 | 1.2 | Buy | |
11/14/23 | Kim Eng | Genting | 0.85 | 1.16 | Buy | |
12/05/23 | UOB Kay Hian | Genting | 0.92 | 1.25 | Buy | |
12/12/23 | CIMB | Genting | 0.96 | 1.3 | Add | |
01/10/24 | Kim Eng | Genting | 1 | 1.21 | Buy | |
01/25/24 | CIMB | Genting | 0.98 | 1.3 | Add | |
01/26/24 | Citi Research | Genting | 0.975 | 1.2 | Buy | |
02/19/24 | UOB Kay Hian | Genting | 1.04 | 1.25 | Buy | EV/Ebitda9x FY24 |
02/23/24 | DBS Vickers | Genting | 1.03 | 1.15 | Buy | Sum of parts |
02/23/24 | Lim & Tan | Genting | 1.03 | 1.22 | Accumulate | |
02/23/24 | Citi Research | Genting | 1.03 | 1.16 | Buy | |
02/23/24 | Kim Eng | Genting | 1.03 | 1.16 | Buy |
Monday, February 26, 2024
Genting - Stock calls
Stock calls for 26 February 2024
Date | Analyst | Company | Last | Target | Call | Valuation |
02/26/24 | UOB Kay Hian | Aztech | 0.92 | 1.25 | Buy | PER9x FY24 |
02/26/24 | CIMB | Aztech | 0.92 | 1.23 | Add | |
02/26/24 | Kim Eng | Aztech | 0.92 | 1.14 | Buy | |
02/26/24 | Kim Eng | Food Empire | 1.42 | 1.6 | Buy | |
02/26/24 | Phillip | HRnetGroup | 0.73 | 0.85 | Buy | PER11x FY24, Ex-cash |
02/26/24 | Kim Eng | HRnetGroup | 0.73 | 0.8 | Hold | |
02/26/24 | phillip | Prime US Reit | 0.128 | 0.3 | Buy | DDM |
02/26/24 | DBS Vickers | Raffles Medical | 1.05 | 1 | Hold | |
02/26/24 | Lim & Tan | Raffles Medical | 1.05 | 1.1 | Hold | |
02/26/24 | UOB Kay Hian | Sasseur | 0.69 | 1.01 | Buy | DDM |
02/26/24 | Citi Research | Sheng Siong | 1.57 | 1.43 | Sell | |
02/26/24 | UOB Kay Hian | Singtel | 2.37 | 2.99 | Buy | DCF |
02/26/24 | Phillip | Singtel | 2.37 | 2.8 | Buy | Sum of parts |
02/26/24 | DBS Vickers | Singtel | 2.37 | 3.27 | Buy | |
02/26/24 | UOB Kay Hian | United Hampshire | 0.445 | 0.68 | Buy | DDM |
02/26/24 | phillip | UOB | 28.25 | 34.9 | Buy | GGM, PB1.41x FY24 |
02/26/24 | Phillip | Venture | 13.72 | 12.75 | Neutral | PER13x FY24/25 |
02/26/24 | Citi Research | Wilmar | 3.39 | 4.38 | Buy | PER12x FY24 |